AeroLeads people directory · profile
Joe Reynolds Email & Phone Number
Executive Director, Global Clinical Development
at
Merck
1 work email found
@c4therapeutics.com
2 phones found area 617
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Executive Director, Global Clinical Development
Location
Watertown, Massachusetts, United States
Who is Joe Reynolds? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Joe Reynolds is listed as Executive Director, Global Clinical Development at Merck, based in Watertown, Massachusetts, United States. AeroLeads shows a work email signal at c4therapeutics.com, phone signal with area code 617, and a matched LinkedIn profile for Joe Reynolds.
Joe Reynolds previously worked as Vice President, Portfolio Strategy and Development Program Leader at C4 Therapeutics, Inc. and Vice President, Development Program Lead at C4 Therapeutics, Inc.. Joe Reynolds holds Doctor Of Philosophy (Phd), Molecular Biology, Cell Biology And Biochemistry from Boston University.
Company email context
Email format at Merck
This section adds company-level context without repeating Joe Reynolds's masked contact details.
{first_initial}{last}@c4therapeutics.com
86% confidence
AeroLeads found 1 current-domain work email signal for Joe Reynolds. Compare company email patterns before reaching out.
Profile bio
About Joe Reynolds
• Demonstrated pharmaceutical leader with experience across all stages of drug development (IND-enabling preclinical work through Phase 1, 2 and 3 studies through approval) spanning oncology, pulmonary disorders and rare diseases• Enterprise leader responsible for Program Management and Portfolio Strategy & Operations functions• Development program leader responsible for cross functional program teams• Advocated for, built, and led the Clinical Science department at Acceleron responsible for all Clinical Science activities across the Acceleron portfolio (including sotatercept for pulmonary arterial hypertension)• Experience with BLA and MAA filings leading to the approval of luspatercept-aamt (REBLOZYL®) for patients with myelodysplastic syndromes (MDS) and beta-thalassemia• Clinical leader responsible for the strategy, establishment, and execution of clinical development plans• Clinical trial experience spanning study start-up through study close out and CSR finalization• Demonstrated record of representing programs with internal and external stakeholders including collaborators (Celgene/Bristol Myers Squibb), senior/executive leadership, Board of Directors, regulatory authorities (FDA, EMA and PMDA), key opinion leaders, investigators, and patient groups
Listed skills include Drug Discovery, Clinical Development, Assay Development, Oncology, and 19 others.
Current workplace
Joe Reynolds's current company
Company context helps verify the profile and gives searchers a useful next step.
13 roles
Joe Reynolds work experience
A career timeline built from the work history available for this profile.
Vice President, Portfolio Strategy And Development Program Leader
Current- Lead for the Program Management and Portfolio Strategy & Operations functions
- Development Program Lead for CFT1946 (in development for the treatment of BRAF V600 mutant solid tumors including NSCLC, melanoma and colorectal cancer) and CFT8634 (previously in development for the treatment of.
Sep 2023 - Present
Vice President, Development Program Lead
- Development Program Lead for CFT8634 and CFT1946
May 2022 - Sep 2023
Senior Director, Global Clinical Lead, Pulmonary Fibrosis
- Global Clinical Lead of a cross functional team to establish and drive the Clinical Strategy and execution of Pulmonary Fibrosis Programs, including ACE-1334 a TGF-beta super-family ligand trap
- Launch of the Phase 1b/2 trial in patients with Systemic Sclerosis (SSc)/SSc-associated interstitial lung disease (SSc-ILD)
- Represent programs to leadership, internal and external stakeholders
- Managed the Clinical Science function within Pulmonary Fibrosis to establish clinical and research collaborations to develop biomarker and translational science plans
Feb 2021 - Apr 2022
Senior Director, Clinical Lead Ace-1334
- Global Clinical Lead for the ACE-1334 program
- Responsible for establishing the clinical strategy and the Clinical Development Plan for ACE-1334
- Responsible the design of the first-in-patient Phase 1b study of ACE-1334 plus standard of care in participants with Systemic Sclerosis (SSc) and SSc-associated interstitial lung disease (SSc-ILD)
- Recruited and managed external relationships including the program Steering Committee
- Managed Clinical Scientists supporting ACE-1334
Jan 2020 - Apr 2022
Senior Director, Head Of Clinical Science
- Head of Clinical Science at Acceleron Pharma managing a team of 5 Clinical Scientists providing support to the companies portfolio
- In collaboration with Celgene/BMS, content author and team member for the submission of the BLA for REBLOZYL (luspatercept-aamt) leading to FDA approval for patients with MDS and beta-thalassemia
- In collaboration with Celgene/BMS, content author and team member for the submission and approval of luspatercept-aamt for Marketing Authorisation by the EMA
- Luspatercept subject matter expert supporting Commercial and Medical Affairs activities for the REBLOZYL launch
- Subject matter expert for luspatercept Clinical Development in response to Health Authority questions
- Clinical Scientist supporting the Clinical Development of luspatercept including the Phase 2 and Phase 3 studies (in collaboration with Celgene/BMS) across multiple indications
Feb 2018 - Feb 2021
Director, Clinical Science
- Director of Clinical Science focusing on:
- The development of luspatercept for myelodysplastic syndromes (MDS) and beta-thalassemia
- The development of sotatercept for pulmonary arterial hypertension (PAH)
Jan 2017 - Jan 2018
Associate Director, Clinical Science And Drug Development
- Associate Director of Clinical Science and Drug Development for MM-302 focusing on:
- Medical monitoring of ongoing studies
- Ensuring maintenance of clinical study conduct
- Overseeing all program-specific clinical science activities
- Relationship building with clinical investigators and key opinion leaders (KOLs)
- Global long-term drug development strategy
Dec 2014 - Jan 2017
Principal Clinical Scientist
- Principal Clinical Scientist for MM-302 focusing on:
- Medical monitoring
- Development of study safety documents
- Development of the strategy for investigator and KOL identification and study recruitment
- Preparation of a briefing documents for regulatory interactions
- Representing the program at regulatory interactions
Dec 2013 - Dec 2014
Senior Clinical Scientist
- Senior Clinical Scientist for MM-302 (a HER2-targeted PEGylated liposomal doxorubicin) focusing on:
- Clinical development
- Oncology clinical trial design, feasibility and implementation
- Synopsis and clinical protocol writing
- Analysis and interpretation of clinical data
- Ensuring maintenance of clinical study conduct
Nov 2012 - Dec 2013
Senior Scientist
- Senior Scientist for MM-302 (a HER2-targeted PEGylated liposomal doxorubicin) focusing on:
- Drug discovery
- Early stage clinical development
- Stem cell-derived cardiac models and their use as a preclinical toxicity screening platform
- High content microscopy (HCM) and quantitative analysis
- Deconvolution microscopy
Jan 2011 - Nov 2012
Scientist
- Scientist for an early stage drug discovery project and MM-302 (a HER2-targeted PEGylated liposomal doxorubicin) focusing on:
- Early stage preclinical drug discovery
- Therapeutic target identification and validation
- IND enabling studies
- Drug mechanism of action
- Microscopy
Jul 2008 - Jan 2011
Call/Volunteer Fire Fighter
Boxford Fire Department
Jun 2012 - Jul 2014
4 education records
Joe Reynolds education
Doctor Of Philosophy (Phd), Molecular Biology, Cell Biology And Biochemistry
Boston University
Master Of Arts (M.A.), Molecular Biology, Cell Biology, & Biochemistry
Boston University
Bachelor Of Science (B.S.), Biochemistry
Bates College
Education record
Winnacunnet High School
FAQ
Frequently asked questions about Joe Reynolds
Quick answers generated from the profile data available on this page.
What company does Joe Reynolds work for?
Joe Reynolds works for Merck.
What is Joe Reynolds's role at Merck?
Joe Reynolds is listed as Executive Director, Global Clinical Development at Merck.
What is Joe Reynolds's email address?
AeroLeads has found 1 work email signal at @c4therapeutics.com for Joe Reynolds at Merck.
What is Joe Reynolds's phone number?
AeroLeads has found 2 phone signal(s) with area code 617 for Joe Reynolds at Merck.
Where is Joe Reynolds based?
Joe Reynolds is based in Watertown, Massachusetts, United States while working with Merck.
What companies has Joe Reynolds worked for?
Joe Reynolds has worked for Merck, C4 Therapeutics, Inc., Acceleron Pharma, Merrimack, and Boxford Fire Department.
How can I contact Joe Reynolds?
You can use AeroLeads to view verified contact signals for Joe Reynolds at Merck, including work email, phone, and LinkedIn data when available.
What schools did Joe Reynolds attend?
Joe Reynolds holds Doctor Of Philosophy (Phd), Molecular Biology, Cell Biology And Biochemistry from Boston University.
What skills is Joe Reynolds known for?
Joe Reynolds is listed with skills including Drug Discovery, Clinical Development, Assay Development, Oncology, Drug Development, Cell Culture, Elisa, and Molecular Biology.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial